Survivin expression in the bone marrow of patients with severe congenital neutropenia

Leukemia

Volumn 23, Issue 3, 2009, Pages 622-625

  Carlsson, G ^a   Boxhammer, S ^a,b   Garwicz, D ^c   Henter, J I ^a   Palmblad, J ^a   Nordenskjold M ^a   Porwit, A ^a   Fadeel, B ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ELA 2 PROTEIN; HAX1 PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; LYMPHOID ENHANCER FACTOR 1; PROTEIN BCL 2; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SURVIVIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE MARROW CELL; CELL CYCLE ARREST; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC CODE; HOMOZYGOSITY; HUMAN; MALE; MYELOPOIESIS; NEUTROPENIA; NEUTROPHIL COUNT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; SCHOOL CHILD;

EID: 62549109119     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.258     Document Type: Article

References (8)

1. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 8: 917-921.
2. Altznauer F, Martinelli S, Yousefi S, Thürig C, Schmid I, Conway EM et al. Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J Exp Med 2004; 199: 1343-1354.
3. Tamm I, Richter S, Oltersdorf D, Creutzig U, Harbott J, Scholz F et al. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia. Clin Cancer Res 2004; 10: 3737-3744.
4. Carlsson G, Aprikyan AA, Tehranchi R, Dale DC, Porwit A, Hellström-Lindberg E et al. Kostmann syndrome: Severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. Blood 2004; 103: 3355-3361.
5. Klein C, Grudzien M, Appaswamy G, Germeshausen M, Sandrock I, Schäffer AA et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2007; 39: 86-92.
6. Skokowa J, Cario G, Uenalan M, Schambach A, Germeshausen M, Battmer K et al. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat Med 2006; 12: 1191-1197.
7. Fukuda S, Pelus LM. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: Implication of survivin expression in normal hematopoiesis. Blood 2001; 98: 2091-2100.
8. Carter BZ, Milella M, Altieri DC, Andreeff M. Cytokine-regulated expression of survivin in myeloid leukemia. Blood 2001; 97: 2784-2790.